Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

THERMO FISHER SCIENTIFIC

(TMO)
  Report
Delayed Nyse  -  04:00 2022-12-08 pm EST
567.95 USD   +1.76%
12/08Thermo Fisher Scientific : Expands its Global Biologics and Steriles Manufacturing Capabilities in China
PU
12/07Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
AQ
12/07RBC Initiates Thermo Fisher Scientific at Outperform With $660 Price Target, Cites 'Advantageous Position'
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific's Cancer Screening Technology Gets FDA Approval

09/28/2022 | 04:53am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ELI LILLY AND COMPANY -0.05% 371.79 Delayed Quote.34.66%
THERMO FISHER SCIENTIFIC 1.76% 567.95 Delayed Quote.-14.88%
All news about THERMO FISHER SCIENTIFIC
12/08Thermo Fisher Scientific : Expands its Global Biologics and Steriles Manufacturing Capabil..
PU
12/07Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
AQ
12/07RBC Initiates Thermo Fisher Scientific at Outperform With $660 Price Target, Cites 'Adv..
MT
12/07Thermo Fisher Scientific Inc. Announces FDA Grants De Novo Classification to HLA Typing..
CI
12/06Thermo Fisher Scientific Raises Greenhouse Gas Emissions Reduction Target on Path to Ne..
BU
12/06Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
CI
11/29Transcript : Thermo Fisher Scientific Inc. Presents at 5th Annual Evercore IS..
CI
11/29Barclays Cuts Price Target on Thermo Fisher to $570 From $575, Maintains Overweight Rat..
MT
11/21Thermo Fisher Scientific Issues 1.25 Billion Euros of 2026, 2034 Notes
MT
11/21Thermo Fisher Scientific Inc. : Entry into a Material Definitive Agreement, Other Events, ..
AQ
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 43 901 M - -
Net income 2022 6 919 M - -
Net Debt 2022 24 827 M - -
P/E ratio 2022 32,4x
Yield 2022 0,21%
Capitalization 224 B 224 B -
EV / Sales 2022 5,66x
EV / Sales 2023 5,54x
Nbr of Employees 130 000
Free-Float 88,9%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 567,95 $
Average target price 617,84 $
Spread / Average Target 8,78%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors